DFFVX
Price
$40.19
Change
+$4.46 (+12.48%)
Updated
Feb 3 closing price
Net Assets
14.92B
LRSRX
Price
$13.73
Change
+$0.16 (+1.18%)
Updated
Feb 3 closing price
Net Assets
383.6M
Interact to see
Advertisement

DFFVX vs LRSRX

Header iconDFFVX vs LRSRX Comparison
Open Charts DFFVX vs LRSRXBanner chart's image
DFA US Targeted Value I
Price$40.19
Change+$4.46 (+12.48%)
VolumeN/A
Net Assets14.92B
Lord Abbett Small Cap Value R3
Price$13.73
Change+$0.16 (+1.18%)
VolumeN/A
Net Assets383.6M
DFFVX vs LRSRX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. LRSRX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and LRSRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.9B vs. LRSRX (384M). DFFVX pays higher dividends than LRSRX: DFFVX (1.58) vs LRSRX (0.14). DFFVX was incepted earlier than LRSRX: DFFVX (26 years) vs LRSRX (18 years). LRSRX (1.46) is less costly to investors than DFFVX (0.30). LRSRX is a more actively managed with annual turnover of: 42.00 vs. DFFVX (10.00). DFFVX (0) and LRSRX (0) have matching initial minimum investment requirements. DFFVX annual gain was more profitable for investors over the last year : 17.44 vs. LRSRX (-0.14). DFFVX return over 5 years is better than : 62.65 vs. LRSRX (-7.96).
DFFVXLRSRXDFFVX / LRSRX
Total Expense Ratio0.291.4620%
Annual Report Gross Expense Ratio0.301.4621%
Fund Existence26 years18 years-
Gain YTD8.6806.599132%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets14.9B384M3,880%
Annual Yield % from dividends1.580.141,118%
Returns for 1 year17.44-0.14-12,262%
Returns for 3 years37.637.26518%
Returns for 5 years62.65-7.96-787%
Returns for 10 years141.58-24.37-581%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCYCX14.370.48
+3.46%
NYLI Candriam Emerging Markets Eq Cl C
EQIRX16.350.22
+1.36%
Allspring Emerging Markets Eq Advtg R6
FVDKX40.52N/A
N/A
Fidelity Value Discovery K
GSURX62.38-0.70
-1.11%
Goldman Sachs US Equity Insights R
VPMAX194.37-2.54
-1.29%
Vanguard PRIMECAP Adm